Table of Contents USA Overactive Bladder Therapeutics Market Report 2012-2023 1 Overactive Bladder Therapeutics Overview 1.1 Product Overview and Scope of Overactive Bladder Therapeutics 1.2 Classification of Overactive Bladder Therapeutics by Product Category 1.2.1 USA Overactive Bladder Therapeutics Sales (K Units) Comparison by Types (2012-2023) 1.2.2 USA Overactive Bladder Therapeutics Sales (K Units) Market Share by Types in 2017 1.2.3 Anti-Muscarinic Agent 1.2.4 Beta-3-Adrenergic Receptor Agonist 1.2.5 Others 1.3 USA Overactive Bladder Therapeutics Market by Application/End Users 1.3.1 USA Overactive Bladder Therapeutics (K Units) and Market Share Comparison by Applications (2012-2023) 1.3.2 Medical Care 1.3.3 Medical Research 1.3.4 Others 1.4 USA Overactive Bladder Therapeutics Market by Region 1.4.1 USA Overactive Bladder Therapeutics Revenue (Million USD) Comparison by Regions (2012-2023) 1.4.2 Northeast Status and Prospect (2012-2023) 1.4.3 Midwest Status and Prospect (2012-2023) 1.4.4 South Status and Prospect (2012-2023) 1.4.5 West Status and Prospect (2012-2023) 1.5 USA Sales and Revenue ofSales and Revenue of Overactive Bladder Therapeutics (2012-2023) 1.5.1 USA Overactive Bladder Therapeutics Sales (K Units) and Growth Rate (2012-2023) 1.5.2 USA Overactive Bladder Therapeutics Revenue (Million USD) and Growth Rate (2012-2023) 2 Industrial Chain Analysis 2.1 Industry Chain Structure of Overactive Bladder Therapeutics 2.2 Raw Material Analysis of Overactive Bladder Therapeutics 2.1.1 Raw Material A Market Analysis 2.1.2 Raw Material B Market Analysis 2.1.3 Raw Material C Market Analysis 2.3 Labor Cost Analysis of Overactive Bladder Therapeutics 2.4 Other Costs Analysis of Overactive Bladder Therapeutics 2.5 Manufacturing Cost Structure Analysis of Overactive Bladder Therapeutics 2.6 Manufacturing Process Analysis of Overactive Bladder Therapeutics 2.7 Raw Materials Sources of Overactive Bladder Therapeutics Major Manufacturers in 2018 2.8 Downstream Buyers 3 USA Overactive Bladder Therapeutics Players/Suppliers Profiles and Sales Data 3.1 Actavis 3.1.1 Company Basic Information, Manufacturing Base and Competitors 3.1.2 Overactive Bladder Therapeutics Product Category, Application and Specification 3.1.2.1 Product A 3.1.2.2 Product B 3.1.3 Actavis Overactive Bladder Therapeutics Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017) 3.1.4 Actavis Different Types of Overactive Bladder Therapeutics Sales (K Units), Revenue (Million USD) and Price (USD/Unit) and (2012-2017) 3.1.5 Actavis Overactive Bladder Therapeutics Volume in Different Applications and Its Application Share 3.2 Allergan 3.2.1 Company Basic Information, Manufacturing Base and Competitors 3.2.2 Overactive Bladder Therapeutics Product Category, Application and Specification 3.2.2.1 Product A 3.2.2.2 Product B 3.2.3 Allergan Overactive Bladder Therapeutics Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017) 3.2.4 Allergan Different Types of Overactive Bladder Therapeutics Sales (K Units), Revenue (Million USD) and Price (USD/Unit) and (2012-2017) 3.2.5 Allergan Overactive Bladder Therapeutics Volume in Different Applications and Its Application Share 3.3 Astellas Pharma 3.3.1 Company Basic Information, Manufacturing Base and Competitors 3.3.2 Overactive Bladder Therapeutics Product Category, Application and Specification 3.3.2.1 Product A 3.3.2.2 Product B 3.3.3 Astellas Pharma Overactive Bladder Therapeutics Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017) 3.3.4 Astellas Pharma Different Types of Overactive Bladder Therapeutics Sales (K Units), Revenue (Million USD) and Price (USD/Unit) and (2012-2017) 3.3.5 Astellas Pharma Overactive Bladder Therapeutics Volume in Different Applications and Its Application Share 3.4 Pfizer 3.4.1 Company Basic Information, Manufacturing Base and Competitors 3.4.2 Overactive Bladder Therapeutics Product Category, Application and Specification 3.4.2.1 Product A 3.4.2.2 Product B 3.4.3 Pfizer Overactive Bladder Therapeutics Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017) 3.4.4 Pfizer Different Types of Overactive Bladder Therapeutics Sales (K Units), Revenue (Million USD) and Price (USD/Unit) and (2012-2017) 3.4.5 Pfizer Overactive Bladder Therapeutics Volume in Different Applications and Its Application Share 3.5 Addex Pharmaceuticals Ltd 3.5.1 Company Basic Information, Manufacturing Base and Competitors 3.5.2 Overactive Bladder Therapeutics Product Category, Application and Specification 3.5.2.1 Product A 3.5.2.2 Product B 3.5.3 Addex Pharmaceuticals Ltd Overactive Bladder Therapeutics Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017) 3.5.4 Addex Pharmaceuticals Ltd Different Types of Overactive Bladder Therapeutics Sales (K Units), Revenue (Million USD) and Price (USD/Unit) and (2012-2017) 3.5.5 Addex Pharmaceuticals Ltd Overactive Bladder Therapeutics Volume in Different Applications and Its Application Share 3.6 Bayer 3.6.1 Company Basic Information, Manufacturing Base and Competitors 3.6.2 Overactive Bladder Therapeutics Product Category, Application and Specification 3.6.2.1 Product A 3.6.2.2 Product B 3.6.3 Bayer Overactive Bladder Therapeutics Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017) 3.6.4 Bayer Different Types of Overactive Bladder Therapeutics Sales (K Units), Revenue (Million USD) and Price (USD/Unit) and (2012-2017) 3.6.5 Bayer Overactive Bladder Therapeutics Volume in Different Applications and Its Application Share 3.7 Elbion 3.7.1 Company Basic Information, Manufacturing Base and Competitors 3.7.2 Overactive Bladder Therapeutics Product Category, Application and Specification 3.7.2.1 Product A 3.7.2.2 Product B 3.7.3 Elbion Overactive Bladder Therapeutics Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017) 3.7.4 Elbion Different Types of Overactive Bladder Therapeutics Sales (K Units), Revenue (Million USD) and Price (USD/Unit) and (2012-2017) 3.7.5 Elbion Overactive Bladder Therapeutics Volume in Different Applications and Its Application Share 3.8 Ipsen 3.8.1 Company Basic Information, Manufacturing Base and Competitors 3.8.2 Overactive Bladder Therapeutics Product Category, Application and Specification 3.8.2.1 Product A 3.8.2.2 Product B 3.8.3 Ipsen Overactive Bladder Therapeutics Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017) 3.8.4 Ipsen Different Types of Overactive Bladder Therapeutics Sales (K Units), Revenue (Million USD) and Price (USD/Unit) and (2012-2017) 3.8.5 Ipsen Overactive Bladder Therapeutics Volume in Different Applications and Its Application Share 3.9 Janssen 3.9.1 Company Basic Information, Manufacturing Base and Competitors 3.9.2 Overactive Bladder Therapeutics Product Category, Application and Specification 3.9.2.1 Product A 3.9.2.2 Product B 3.9.3 Janssen Overactive Bladder Therapeutics Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017) 3.9.4 Janssen Different Types of Overactive Bladder Therapeutics Sales (K Units), Revenue (Million USD) and Price (USD/Unit) and (2012-2017) 3.9.5 Janssen Overactive Bladder Therapeutics Volume in Different Applications and Its Application Share 3.10 Kissei Pharma 3.10.1 Company Basic Information, Manufacturing Base and Competitors 3.10.2 Overactive Bladder Therapeutics Product Category, Application and Specification 3.10.2.1 Product A 3.10.2.2 Product B 3.10.3 Kissei Pharma Overactive Bladder Therapeutics Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017) 3.10.4 Kissei Pharma Different Types of Overactive Bladder Therapeutics Sales (K Units), Revenue (Million USD) and Price (USD/Unit) and (2012-2017) 3.10.5 Kissei Pharma Overactive Bladder Therapeutics Volume in Different Applications and Its Application Share 4 USA Overactive Bladder Therapeutics Competition by Players/Manufacturers, Region, Type and Application 4.1 USA Overactive Bladder Therapeutics Market Competition by Players/Manufacturers 4.1.1 USA Overactive Bladder Therapeutics Sales (K Units) and Market Share of Key Players/Suppliers (2012-2017) 4.1.2 USA Overactive Bladder Therapeutics Revenue (Million USD) and Share by Players/Suppliers (2012-2017) 4.2 USA Overactive Bladder Therapeutics Sales and Revenue by Type 4.2.1 USA Overactive Bladder Therapeutics Sales (K Units) and Market Share by Type (2012-2017) 4.2.2 USA Overactive Bladder Therapeutics Revenue (Million USD) and Market Share by Type (2012-2017) 4.3 USA Overactive Bladder Therapeutics Sales and Revenue by Application 4.3.1 USA Overactive Bladder Therapeutics Sales (K Units) and Market Share by Regions (2012-2017) 4.3.2 USA Overactive Bladder Therapeutics Revenue (Million USD) and Market Share (%) Regions (2012-2017) 4.4 USA Overactive Bladder Therapeutics Sales (K Units) by Application 5 Northeast Overactive Bladder Therapeutics (Sales, Revenue and Price) 5.1 Northeast Overactive Bladder Therapeutics Sales and Value (2012-2017) 5.1.1 Northeast Overactive Bladder Therapeutics Sales (K Units) and Growth Rate (2012-2017) 5.1.2 Northeast Overactive Bladder Therapeutics Revenue and Growth Rate (2012-2017) 5.1.3 Northeast Overactive Bladder Therapeutics Sales Price (USD/Unit) Trend (2012-2017) 5.2 Northeast Overactive Bladder Therapeutics Sales (K Units) and Market Share by Type 5.3 Northeast Overactive Bladder Therapeutics Sales (K Units) and Market Share by Application 6 Midwest Overactive Bladder Therapeutics (Sales, Revenue and Price) 6.1 Midwest Overactive Bladder Therapeutics Sales and Value (2012-2017) 6.1.1 Midwest Overactive Bladder Therapeutics Sales (K Units) and Growth Rate (2012-2017) 6.1.2 Midwest Overactive Bladder Therapeutics Revenue and Growth Rate (2012-2017) 6.1.3 Midwest Overactive Bladder Therapeutics Sales Price (USD/Unit) Trend (2012-2017) 6.2 Midwest Overactive Bladder Therapeutics Sales (K Units) and Market Share by Type 6.3 Midwest Overactive Bladder Therapeutics Sales (K Units) and Market Share by Application 7 South Overactive Bladder Therapeutics (Sales, Revenue and Price) 7.1 South Overactive Bladder Therapeutics Sales and Value (2012-2017) 7.1.1 South Overactive Bladder Therapeutics Sales (K Units) and Growth Rate (2012-2017) 7.1.2 South Overactive Bladder Therapeutics Revenue and Growth Rate (2012-2017) 7.1.3 South Overactive Bladder Therapeutics Sales Price (USD/Unit) Trend (2012-2017) 7.2 South Overactive Bladder Therapeutics Sales (K Units) and Market Share by Type 7.3 South Overactive Bladder Therapeutics Sales (K Units) and Market Share by Application 8 West Overactive Bladder Therapeutics (Sales, Revenue and Price) 8.1 West Overactive Bladder Therapeutics Sales and Value (2012-2017) 8.1.1 West Overactive Bladder Therapeutics Sales (K Units) and Growth Rate (2012-2017) 8.1.2 West Overactive Bladder Therapeutics Revenue and Growth Rate (2012-2017) 8.1.3 West Overactive Bladder Therapeutics Sales Price (USD/Unit) Trend (2012-2017) 8.2 West Overactive Bladder Therapeutics Sales (K Units) and Market Share by Type 8.3 West Overactive Bladder Therapeutics Sales (K Units) and Market Share by Application 11 Marketing Strategy Analysis, Distributors/Traders 11.1 Direct Marketing 11.1.1 Direct Marketing 11.1.2 Indirect Marketing 11.1.3 Marketing Channel Development Trend 11.2 Market Positioning 11.2.1 Pricing Strategy 11.2.2 Brand Strategy 11.2.3 Target Client 11.3 Distributors/Traders List 12 USA Overactive Bladder Therapeutics Market Forecast (2018-2023) 12.1 USA Overactive Bladder Therapeutics Sales (K Units), Revenue and Price Forecast (2018-2023) 12.1.1 USA Overactive Bladder Therapeutics Sales (K Units) and Growth Rate Forecast (2018-2023) 12.1.2 USA Overactive Bladder Therapeutics Revenue and Growth Rate Forecast (2018-2023) 12.1.3 USA Overactive Bladder Therapeutics Price and Trend Forecast (2018-2023) 12.2 USA Overactive Bladder Therapeutics Sales (K Units), Revenue and Growth Rate Forecast by Region (2018-2023) 12.2.1 USA Overactive Bladder Therapeutics Sales (K Units) and Growth Rate Forecast by Region (2018-2023) 12.2.2 USA Overactive Bladder Therapeutics Revenue and Growth Rate Forecast by Region (2018-2023) 12.2.3 Northeast Overactive Bladder Therapeutics Sales, Revenue and Growth Rate Forecast (2018-2023) 12.2.4 Midwest Overactive Bladder Therapeutics Sales, Revenue and Growth Rate Forecast (2018-2023) 12.2.5 Midwest Overactive Bladder Therapeutics Sales, Revenue and Growth Rate Forecast (2018-2023) 12.2.6 West Overactive Bladder Therapeutics Sales, Revenue and Growth Rate Forecast (2018-2023) 12.3 USA Overactive Bladder Therapeutics Sales, Revenue and Price Forecast by Type (2018-2023) 12.3.1 USA Overactive Bladder Therapeutics Sales Forecast by Type (2018-2023) 12.3.2 USA Overactive Bladder Therapeutics Revenue Forecast by Type (2018-2023) 12.3.3 USA Overactive Bladder Therapeutics Price Forecast by Type (2018-2023) 12.4 USA Overactive Bladder Therapeutics Sales Forecast by Application (2018-2023) 13 Research Findings and Conclusion 14 Appendix 14.1 Methodology/Research Approach 14.1.1 Research Programs/Design 14.1.2 Market Size Estimation 14.1.3 Market Breakdown and Data Triangulation 14.2 Data Source 14.2.1 Secondary Sources 14.2.2 Primary Sources 14.3 Disclaimer

List of Tables and Figures Figure USA Market Size (Million USD) Comparison 2012-2023 Table USA Market Overactive Bladder Therapeutics Revenue (Million USD) Comparison by Regions 2012-2023 Table USA Overactive Bladder Therapeutics Sales (K Units) and Revenue (Million USD) Market Split by Product Type Table USA Overactive Bladder Therapeutics Sales (K Units) by Application (2016-2023) Figure Product Picture of Overactive Bladder Therapeutics Table USA Overactive Bladder Therapeutics Sales (K Units) and Growth Rate (%) Comparison by Types (2012-2023) Figure USA Overactive Bladder Therapeutics Sales (K Units) Market Share by Types in 2017 Figure Anti-Muscarinic Agent Picture Figure Beta-3-Adrenergic Receptor Agonist Picture Figure Others Picture Table USA Overactive Bladder Therapeutics Sales (K Units) Comparison by Applications (2012-2023) Figure USA Sales Market Share of Overactive Bladder Therapeutics by Applications in 2017 Figure Medical Care Examples Figure Medical Research Examples Figure Others Examples Table USA Market Overactive Bladder Therapeutics Revenue (Million USD) Comparison by Regions 2012-2023 Figure Northeast Overactive Bladder Therapeutics Revenue (Million USD) and Growth Rate (2012-2023) Figure Midwest Overactive Bladder Therapeutics Revenue (Million USD) and Growth Rate (2012-2023) Figure South Overactive Bladder Therapeutics Revenue (Million USD) and Growth Rate (2012-2023) Figure West Overactive Bladder Therapeutics Revenue (Million USD) and Growth Rate (2012-2023) Figure USA Overactive Bladder Therapeutics Sales (K Units) and Growth Rate (2012-2023) Figure USA Overactive Bladder Therapeutics Revenue (Million USD) and Growth Rate (2012-2023) Figure New Project SWOT Analysis of Overactive Bladder Therapeutics Table Industry News List of Overactive Bladder Therapeutics Figure Industry Chain Structure of Overactive Bladder Therapeutics Table Raw Material Suppliers and Price Analysis Figure Global Raw Material A Price Trend (USD/MT) Figure Global Raw Material B Price Trend (USD/MT) Figure Global Raw Material C Price Trend (USD/MT) Table Manufacturing Cost Structure Analysis of Overactive Bladder Therapeutics in 2017 Figure Manufacturing Process Analysis of Overactive Bladder Therapeutics Table Raw Materials Sources of Overactive Bladder Therapeutics Major Manufacturers in 2017 Table Major Buyers of Overactive Bladder Therapeutics Table Actavis Basic Information List Table Actavis Overactive Bladder Therapeutics Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017) Figure Actavis Overactive Bladder Therapeutics Sales Growth Rate (2012-2017) Figure Actavis Overactive Bladder Therapeutics Sales USA Market Share (%) (2012-2017) Figure Actavis Overactive Bladder Therapeutics Revenue USA Market Share (%) (2012-2017) Table Anti-Muscarinic Agent Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) Table Beta-3-Adrenergic Receptor Agonist Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) Table Others Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) Table Actavis Overactive Bladder Therapeutics Volume in and Its Application Share Table Actavis Overactive Bladder Therapeutics Volume in and Its Application Share Table Actavis Overactive Bladder Therapeutics Volume in and Its Application Share Table Allergan Basic Information List Table Allergan Overactive Bladder Therapeutics Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017) Figure Allergan Overactive Bladder Therapeutics Sales Growth Rate (2012-2017) Figure Allergan Overactive Bladder Therapeutics Sales USA Market Share (%) (2012-2017) Figure Allergan Overactive Bladder Therapeutics Revenue USA Market Share (%) (2012-2017) Table Anti-Muscarinic Agent Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) Table Beta-3-Adrenergic Receptor Agonist Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) Table Others Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) Table Allergan Overactive Bladder Therapeutics Volume in and Its Application Share Table Allergan Overactive Bladder Therapeutics Volume in and Its Application Share Table Allergan Overactive Bladder Therapeutics Volume in and Its Application Share Table Astellas Pharma Basic Information List Table Astellas Pharma Overactive Bladder Therapeutics Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017) Figure Astellas Pharma Overactive Bladder Therapeutics Sales Growth Rate (2012-2017) Figure Astellas Pharma Overactive Bladder Therapeutics Sales USA Market Share (%) (2012-2017) Figure Astellas Pharma Overactive Bladder Therapeutics Revenue USA Market Share (%) (2012-2017) Table Anti-Muscarinic Agent Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) Table Beta-3-Adrenergic Receptor Agonist Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) Table Others Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) Table Astellas Pharma Overactive Bladder Therapeutics Volume in and Its Application Share Table Astellas Pharma Overactive Bladder Therapeutics Volume in and Its Application Share Table Astellas Pharma Overactive Bladder Therapeutics Volume in and Its Application Share Table Pfizer Basic Information List Table Pfizer Overactive Bladder Therapeutics Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017) Figure Pfizer Overactive Bladder Therapeutics Sales Growth Rate (2012-2017) Figure Pfizer Overactive Bladder Therapeutics Sales USA Market Share (%) (2012-2017) Figure Pfizer Overactive Bladder Therapeutics Revenue USA Market Share (%) (2012-2017) Table Anti-Muscarinic Agent Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) Table Beta-3-Adrenergic Receptor Agonist Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) Table Others Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) Table Pfizer Overactive Bladder Therapeutics Volume in and Its Application Share Table Pfizer Overactive Bladder Therapeutics Volume in and Its Application Share Table Pfizer Overactive Bladder Therapeutics Volume in and Its Application Share Table Addex Pharmaceuticals Ltd Basic Information List Table Addex Pharmaceuticals Ltd Overactive Bladder Therapeutics Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017) Figure Addex Pharmaceuticals Ltd Overactive Bladder Therapeutics Sales Growth Rate (2012-2017) Figure Addex Pharmaceuticals Ltd Overactive Bladder Therapeutics Sales USA Market Share (%) (2012-2017) Figure Addex Pharmaceuticals Ltd Overactive Bladder Therapeutics Revenue USA Market Share (%) (2012-2017) Table Anti-Muscarinic Agent Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) Table Beta-3-Adrenergic Receptor Agonist Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) Table Others Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) Table Addex Pharmaceuticals Ltd Overactive Bladder Therapeutics Volume in and Its Application Share Table Addex Pharmaceuticals Ltd Overactive Bladder Therapeutics Volume in and Its Application Share Table Addex Pharmaceuticals Ltd Overactive Bladder Therapeutics Volume in and Its Application Share Table Bayer Basic Information List Table Bayer Overactive Bladder Therapeutics Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017) Figure Bayer Overactive Bladder Therapeutics Sales Growth Rate (2012-2017) Figure Bayer Overactive Bladder Therapeutics Sales USA Market Share (%) (2012-2017) Figure Bayer Overactive Bladder Therapeutics Revenue USA Market Share (%) (2012-2017) Table Anti-Muscarinic Agent Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) Table Beta-3-Adrenergic Receptor Agonist Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) Table Others Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) Table Bayer Overactive Bladder Therapeutics Volume in and Its Application Share Table Bayer Overactive Bladder Therapeutics Volume in and Its Application Share Table Bayer Overactive Bladder Therapeutics Volume in and Its Application Share Table Elbion Basic Information List Table Elbion Overactive Bladder Therapeutics Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017) Figure Elbion Overactive Bladder Therapeutics Sales Growth Rate (2012-2017) Figure Elbion Overactive Bladder Therapeutics Sales USA Market Share (%) (2012-2017) Figure Elbion Overactive Bladder Therapeutics Revenue USA Market Share (%) (2012-2017) Table Anti-Muscarinic Agent Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) Table Beta-3-Adrenergic Receptor Agonist Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) Table Others Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) Table Elbion Overactive Bladder Therapeutics Volume in and Its Application Share Table Elbion Overactive Bladder Therapeutics Volume in and Its Application Share Table Elbion Overactive Bladder Therapeutics Volume in and Its Application Share Table Ipsen Basic Information List Table Ipsen Overactive Bladder Therapeutics Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017) Figure Ipsen Overactive Bladder Therapeutics Sales Growth Rate (2012-2017) Figure Ipsen Overactive Bladder Therapeutics Sales USA Market Share (%) (2012-2017) Figure Ipsen Overactive Bladder Therapeutics Revenue USA Market Share (%) (2012-2017) Table Anti-Muscarinic Agent Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) Table Beta-3-Adrenergic Receptor Agonist Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) Table Others Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) Table Ipsen Overactive Bladder Therapeutics Volume in and Its Application Share Table Ipsen Overactive Bladder Therapeutics Volume in and Its Application Share Table Ipsen Overactive Bladder Therapeutics Volume in and Its Application Share Table Janssen Basic Information List Table Janssen Overactive Bladder Therapeutics Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017) Figure Janssen Overactive Bladder Therapeutics Sales Growth Rate (2012-2017) Figure Janssen Overactive Bladder Therapeutics Sales USA Market Share (%) (2012-2017) Figure Janssen Overactive Bladder Therapeutics Revenue USA Market Share (%) (2012-2017) Table Anti-Muscarinic Agent Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) Table Beta-3-Adrenergic Receptor Agonist Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) Table Others Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) Table Janssen Overactive Bladder Therapeutics Volume in and Its Application Share Table Janssen Overactive Bladder Therapeutics Volume in and Its Application Share Table Janssen Overactive Bladder Therapeutics Volume in and Its Application Share Table Company Kissei Pharma Basic Information List Table Company Kissei Pharma Overactive Bladder Therapeutics Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017) Figure Company Kissei Pharma Overactive Bladder Therapeutics Sales Growth Rate (2012-2017) Figure Company Kissei Pharma Overactive Bladder Therapeutics Sales USA Market Share (%) (2012-2017) Figure Company Kissei Pharma Overactive Bladder Therapeutics Revenue USA Market Share (%) (2012-2017) Table Anti-Muscarinic Agent Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) Table Beta-3-Adrenergic Receptor Agonist Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) Table Others Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) Table Company Kissei Pharma Overactive Bladder Therapeutics Volume in and Its Application Share Table Company Kissei Pharma Overactive Bladder Therapeutics Volume in and Its Application Share Table Company Kissei Pharma Overactive Bladder Therapeutics Volume in and Its Application Share Table USA Overactive Bladder Therapeutics Sales (K Units) by Players/Manufacturers (2012-2017) Table USA Overactive Bladder Therapeutics Sales Share (%) by Players/Manufacturers (2012-2017) Figure 2016 USA Overactive Bladder Therapeutics Sales Market Share (%) by Players/Manufacturers Figure 2017 USA Overactive Bladder Therapeutics Sales Share by Players/Manufacturers Table USA Overactive Bladder Therapeutics Revenue (Million USD) by Players/Manufacturers (2012-2017) Table USA Overactive Bladder Therapeutics Revenue Market Share (%) Players/Manufacturers (2012-2017) Figure 2016 USA Overactive Bladder Therapeutics Revenue Market Share (%) Players Figure 2017 USA Overactive Bladder Therapeutics Revenue Market Share (%) Players Table USA Overactive Bladder Therapeutics Sales (K Units) and Market Share (%) by Type (2012-2017) Table USA Overactive Bladder Therapeutics Sales Share by Type (2012-2017) Figure Sales Market Share of Overactive Bladder Therapeutics by Type (2012-2017) Figure USA Overactive Bladder Therapeutics Sales Growth Rate (%) by Type (2012-2017) Table USA Overactive Bladder Therapeutics Revenue (Million USD) and Market Share (%) Type (2012-2017) Table USA Overactive Bladder Therapeutics Revenue Market Share (%) Type (2012-2017) Figure Revenue Market Share of Overactive Bladder Therapeutics by Type (2012-2017) Figure USA Overactive Bladder Therapeutics Revenue Growth Rate by Type (2012-2017) Table USA Overactive Bladder Therapeutics Sales (K Units) and Market Share by Regions (2012-2017) Table USA Overactive Bladder Therapeutics Sales Share by Regions (2012-2017) Figure Sales Market Share of Overactive Bladder Therapeutics by Regions (2012-2017) Figure USA Overactive Bladder Therapeutics Sales Market Share by Regions in 2017 Table USA Overactive Bladder Therapeutics Revenue (Million USD) and Market Share by Regions (2012-2017) Table USA Overactive Bladder Therapeutics Revenue Share (%) by Regions (2012-2017) Figure Revenue Market Share of Overactive Bladder Therapeutics by Regions (2012-2017) Figure USA Overactive Bladder Therapeutics Revenue Market Share by Regions in 2017 Table USA Overactive Bladder Therapeutics Sales (K Units) and Market Share by Application (2012-2017) Table USA Overactive Bladder Therapeutics Sales Share (%) by Application (2012-2017) Figure USA Overactive Bladder Therapeutics Sales Market Share by Application (2012-2017) Figure USA Overactive Bladder Therapeutics Sales Market Share by Application (2012-2017) Figure Northeast Overactive Bladder Therapeutics Sales (K Units) and Growth Rate (%) (2012-2017) Figure Northeast Overactive Bladder Therapeutics Revenue (Million USD) and Growth Rate (%) (2012-2017) Figure Northeast Overactive Bladder Therapeutics Sales Price (USD/Unit) Trend (2012-2017) Table Northeast Overactive Bladder Therapeutics Sales (K Units) by Type (2012-2017) Table Northeast Overactive Bladder Therapeutics Sales (K Units) Market Share by Type (2012-2017) Figure Northeast Overactive Bladder Therapeutics Sales (K Units) Market Share by Type in 2017 Table Northeast Overactive Bladder Therapeutics Sales (K Units) by Applications (2012-2017) Table Northeast Overactive Bladder Therapeutics Sales (K Units) Market Share by Applications (2012-2017) Figure Northeast Overactive Bladder Therapeutics Sales (K Units) Market Share by Applications in 2017 Figure Midwest Overactive Bladder Therapeutics Sales (K Units) and Growth Rate (2012-2017) Figure Midwest Overactive Bladder Therapeutics Revenue (Million USD) and Growth Rate (%) (2012-2017) Figure Midwest Overactive Bladder Therapeutics Sales Price (USD/Unit) Trend (2012-2017) Table Midwest Overactive Bladder Therapeutics Sales (K Units) by Type (2012-2017) Table Midwest Overactive Bladder Therapeutics Sales (K Units) Market Share by Type (2012-2017) Figure Midwest Overactive Bladder Therapeutics Sales (K Units) Market Share by Type in 2017 Table Midwest Overactive Bladder Therapeutics Sales (K Units) by Applications (2012-2017) Table Midwest Overactive Bladder Therapeutics Sales (K Units) Market Share by Applications (2012-2017) Figure Midwest Overactive Bladder Therapeutics Sales (K Units) Market Share by Applications in 2017 Figure South Overactive Bladder Therapeutics Sales (K Units) and Growth Rate (2012-2017) Figure South Overactive Bladder Therapeutics Revenue (Million USD) and Growth Rate (%) (2012-2017) Figure South Overactive Bladder Therapeutics Sales Price (USD/Unit) Trend (2012-2017) Table South Overactive Bladder Therapeutics Sales (K Units) by Type (2012-2017) Table South Overactive Bladder Therapeutics Sales (K Units) Market Share by Type (2012-2017) Figure South Overactive Bladder Therapeutics Sales (K Units) Market Share by Type in 2017 Table South Overactive Bladder Therapeutics Sales (K Units) by Applications (2012-2017) Table South Overactive Bladder Therapeutics Sales (K Units) Market Share by Applications (2012-2017) Figure South Overactive Bladder Therapeutics Sales (K Units) Market Share by Applications in 2017 Figure West Overactive Bladder Therapeutics Sales (K Units) and Growth Rate (2012-2017) Figure West Overactive Bladder Therapeutics Revenue (Million USD) and Growth Rate (%) (2012-2017) Figure West Overactive Bladder Therapeutics Sales Price (USD/Unit) Trend (2012-2017) Table West Overactive Bladder Therapeutics Sales (K Units) by Type (2012-2017) Table West Overactive Bladder Therapeutics Sales (K Units) Market Share by Type (2012-2017) Figure West Overactive Bladder Therapeutics Sales (K Units) Market Share by Type in 2017 Table West Overactive Bladder Therapeutics Sales (K Units) by Applications (2012-2017) Table West Overactive Bladder Therapeutics Sales (K Units) Market Share by Applications (2012-2017) Figure West Overactive Bladder Therapeutics Sales (K Units) Market Share by Applications in 2017 Table Distributors/Traders List Figure USA Overactive Bladder Therapeutics Sales (K Units) and Growth Rate Forecast (2018-2023) Figure USA Overactive Bladder Therapeutics Revenue (Million USD) and Growth Rate (%) Forecast (2018-2023) Figure USA Overactive Bladder Therapeutics Price and Trend Forecast (2018-2023) Table USA Overactive Bladder Therapeutics Sales (K Units) Forecast by Regions (2018-2023) Figure USA Overactive Bladder Therapeutics Sales (K Units) Market Share Forecast by Regions (2018-2023) Figure USA Overactive Bladder Therapeutics Sales (K Units) Market Share Forecast by Regions in 2023 Table USA Overactive Bladder Therapeutics Revenue (Million USD) Forecast by Regions (2018-2023) Figure USA Overactive Bladder Therapeutics Revenue Market Share Forecast by Regions (2018-2023) Figure USA Overactive Bladder Therapeutics Revenue Market Share Forecast by Regions in 2023 Figure Northeast Overactive Bladder Therapeutics Sales (K Units) and Growth Rate (%) Forecast (2018-2023) Figure Northeast Overactive Bladder Therapeutics Revenue (Million USD) and Growth Rate (%) Forecast (2018-2023) Figure South Overactive Bladder Therapeutics Sales (K Units) and Growth Rate (%) Forecast (2018-2023) Figure South Overactive Bladder Therapeutics Revenue (Million USD) and Growth Rate (%) Forecast (2018-2023) Figure Midwest Overactive Bladder Therapeutics Sales (K Units) and Growth Rate (%) Forecast (2018-2023) Figure Midwest Overactive Bladder Therapeutics Revenue (Million USD) and Growth Rate (%) Forecast (2018-2023) Figure West Overactive Bladder Therapeutics Sales (K Units) and Growth Rate (%) Forecast (2018-2023) Figure West Overactive Bladder Therapeutics Revenue (Million USD) and Growth Rate (%) Forecast (2018-2023) Table USA Overactive Bladder Therapeutics Sales (K Units) Forecast by Type (2018-2023) Figure USA Overactive Bladder Therapeutics Sales Market Share Forecast by Type (2018-2023) Table USA Overactive Bladder Therapeutics Revenue (Million USD) Forecast by Type (2018-2023) Figure USA Overactive Bladder Therapeutics Revenue Market Share Forecast by Type (2018-2023) Table USA Overactive Bladder Therapeutics Price (USD/Unit) Forecast by Type (2018-2023) Table USA Overactive Bladder Therapeutics Sales (K Units) Forecast by Application (2018-2023) Figure USA Overactive Bladder Therapeutics Sales Market Share Forecast by Application (2018-2023) Table Research Programs/Design for This Report Figure Bottom-up and Top-down Approaches for This Report Figure Data Triangulation Table Key Data Information from Secondary Sources Table Key Data Information from Primary Sources

Actavis Allergan Astellas Pharma Pfizer Addex Pharmaceuticals Ltd Bayer Elbion Ipsen Janssen Kissei Pharma